Free Trial

Agilon Health (NYSE:AGL) Shares Down 4.3% - Time to Sell?

Agilon Health logo with Medical background

Key Points

  • Agilon Health's stock price dropped 4.3% to $1.22, with a trading volume significantly lower than average at 985,813 shares.
  • Analysts have downgraded their price targets for Agilon Health, with Jefferies reducing their estimate from $2.40 to $1.10, and a consensus target now at $3.07.
  • The company reported a quarterly loss of ($0.25) EPS, missing expectations, with revenue of $1.39 billion compared to an estimated $1.47 billion.
  • MarketBeat previews top five stocks to own in October.

Agilon Health, Inc. (NYSE:AGL - Get Free Report)'s stock price traded down 4.3% during mid-day trading on Wednesday . The stock traded as low as $1.21 and last traded at $1.22. 985,813 shares traded hands during trading, a decline of 86% from the average session volume of 7,132,447 shares. The stock had previously closed at $1.27.

Analysts Set New Price Targets

Several brokerages recently weighed in on AGL. Jefferies Financial Group cut their price objective on shares of Agilon Health from $2.40 to $1.10 and set a "hold" rating on the stock in a report on Friday, August 15th. Wells Fargo & Company dropped their target price on Agilon Health from $6.00 to $5.00 and set an "overweight" rating for the company in a report on Tuesday, May 13th. Barclays reduced their price target on shares of Agilon Health from $3.00 to $1.50 and set an "underweight" rating on the stock in a research report on Wednesday, August 6th. Benchmark cut their price objective on Agilon Health from $4.00 to $1.50 and set a "buy" rating on the stock in a report on Wednesday, August 6th. Finally, Evercore ISI cut their target price on Agilon Health from $5.00 to $3.00 and set an "in-line" rating on the stock in a research report on Wednesday, July 9th. Four investment analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $3.07.

Read Our Latest Research Report on Agilon Health

Agilon Health Trading Down 4.3%

The firm has a market cap of $503.52 million, a P/E ratio of -1.58 and a beta of 0.11. The stock's fifty day moving average is $1.74 and its two-hundred day moving average is $2.88.

Agilon Health (NYSE:AGL - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The company reported ($0.25) EPS for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. The firm had revenue of $1.39 billion for the quarter, compared to analysts' expectations of $1.47 billion. During the same quarter last year, the firm earned ($0.07) earnings per share. The firm's revenue for the quarter was down 5.9% on a year-over-year basis. On average, analysts forecast that Agilon Health, Inc. will post -0.59 EPS for the current year.

Institutional Investors Weigh In On Agilon Health

Hedge funds have recently added to or reduced their stakes in the company. Wells Fargo & Company MN increased its position in shares of Agilon Health by 47.5% during the 4th quarter. Wells Fargo & Company MN now owns 144,763 shares of the company's stock valued at $275,000 after purchasing an additional 46,645 shares during the last quarter. Raymond James Financial Inc. bought a new position in Agilon Health during the fourth quarter valued at approximately $33,000. Dimensional Fund Advisors LP raised its stake in shares of Agilon Health by 25.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 255,914 shares of the company's stock worth $486,000 after acquiring an additional 51,852 shares in the last quarter. MetLife Investment Management LLC lifted its holdings in shares of Agilon Health by 4.0% in the 4th quarter. MetLife Investment Management LLC now owns 174,551 shares of the company's stock worth $332,000 after acquiring an additional 6,762 shares during the last quarter. Finally, Hsbc Holdings PLC lifted its holdings in shares of Agilon Health by 205.3% in the 4th quarter. Hsbc Holdings PLC now owns 132,952 shares of the company's stock worth $249,000 after acquiring an additional 89,407 shares during the last quarter.

Agilon Health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Agilon Health Right Now?

Before you consider Agilon Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.

While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.